by MDB Manager | Feb 19, 2025 | Press Releases
Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) — eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels – today announced that CEO Michael Heltzen...
by MDB Manager | Feb 12, 2025 | Press Releases
Rebranding Invizyne Technologies, Inc to eXoZymes Inc. Changing NASDAQ ticker from IZTC to EXOZ Introducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE NEWSWIRE) — Today, Invizyne Technologies, Inc....
by Staff | Feb 10, 2025 | Press Releases
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025. Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) — Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) (“Invizyne”), a leading designer of cell-free, enzyme-based biomanufacturing...
Recent Comments